Jeffrey N. Simmons - 11 Dec 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
PRESIDENT, CEO AND DIRECTOR, Director
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol
ELAN
Transactions as of
11 Dec 2025
Net transactions value
+$478,496
Form type
4
Filing time
15 Dec 2025, 16:41:24 UTC
Previous filing
02 Dec 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR, Director C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS /s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons 15 Dec 2025 0001479079

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Purchase $478,496 +22,000 +15% $21.75 167,000 11 Dec 2025 By Revocable Trust F1
holding ELAN Common Stock 1,802,380 11 Dec 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 22,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.739 to $21.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 1 share acquired on April 30, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.